Science Times Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.

Press releases published on October 28, 2026

Oct. 28, 2026

Trident Founder & CEO to Buy Up to 1,000,000 Shares in the Open Market

Indeterminate GlobeNewswire

Oct. 28, 2026

Aemetis to Review Third Quarter 2026 Financial Results on November 5, 2026

Indeterminate GlobeNewswire

Oct. 28, 2026

Wheelchair-Bound to Walking: Guntur Neurosurgeon Reports 5-Year Spine Surgery Outcome at SBNS 100

Indeterminate EIN Presswire

Oct. 28, 2026

Circuit Mind Announces $25M in Funding to Accelerate the Rise of Electronic Design Intelligence

Indeterminate GlobeNewswire

Oct. 28, 2026

Circuit Mind Launches AVE, Extending Its Electronic Design Intelligence Platform with AI-Powered Design Verification

Indeterminate GlobeNewswire

Oct. 28, 2026

ProQR to Present Clinical and Preclinical Progress from AX-0810 and AX-0811 at Upcoming Conferences

Indeterminate GlobeNewswire

Oct. 28, 2026

Kensington and EPOS Showcase End-to-End Professional Workspace Technology at Pepcom Holiday Spectacular! 2026

Indeterminate GlobeNewswire

Oct. 28, 2026

Supply’d Intelligence Brings AI Agents and Connected Assistants to Food Industry ERP

Indeterminate GlobeNewswire

Oct. 28, 2026

Neumarker Enter Collaboration to Advance Precision Medicine in Depression

Indeterminate GlobeNewswire

Oct. 28, 2026

Bob Hiring, a Core HiBob Solution Awarded Leader Placement in Nucleus Research’s 2026 Full-Suite Talent Acquisition Value Matrix

Indeterminate GlobeNewswire

Oct. 28, 2026

TCG Labs Soleil Highlights Portfolio Momentum with Three Programs Entering First-in-Human Clinical Trials Across Oncology and Cardiovascular Disease

Indeterminate GlobeNewswire

Oct. 28, 2026

Noom Study Finds Members Further Along in Its GLP-1Rx Program Report Higher “Flourishing” and “Quality of Life”

Indeterminate GlobeNewswire

Oct. 28, 2026

Annexon to Host Virtual Investor Event on November 3, 2026: Vonaprument for the Treatment of Geographic Atrophy - Highlighting Key Aspects of Phase 3 ARCHER II Trial

Indeterminate GlobeNewswire

Oct. 28, 2026

electroCore, Inc. Submits 510(k) Premarket Notification to FDA Seeking Clearance of Quell® for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Indeterminate GlobeNewswire

Oct. 28, 2026

Satellogic Schedules Third Quarter 2026 Results Conference Call on Tuesday, November 10, 2026, at 4:30 p.m. Eastern Time

Indeterminate GlobeNewswire

Oct. 28, 2026

Sofwave to Participate in Upcoming November Investor Conferences

Indeterminate GlobeNewswire

Oct. 28, 2026

Mitesco Appoints Senior Executive to the Board of Directors

Indeterminate GlobeNewswire

Oct. 28, 2026

Ivans Index Q3 2026 Results Released

Indeterminate GlobeNewswire

Oct. 28, 2026

Geron Corporation Provides Update on Phase 3 IMpactMF Clinical Trial of Imetelstat in Relapsed/Refractory Myelofibrosis

Indeterminate GlobeNewswire

Oct. 28, 2026

Humacyte Strengthens Intellectual Property Portfolio with Issuance of New U.S. Patent Covering Symvess and Other Bioengineered Tissues

Indeterminate GlobeNewswire